ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

15 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

14 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

14 11 2023 02:05:00 提供 Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

26 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

21 9 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci to Host R&D Day on October 4, 2023

06 9 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

28 8 2023 16:05:00 提供 Nasdaq GlobeNewswire

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

14 8 2023 08:02:00 提供 Nasdaq GlobeNewswire

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

14 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development

10 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023

01 8 2023 08:00:01 提供 Nasdaq GlobeNewswire

Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 7 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

15 6 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

06 6 2023 08:00:02 提供 Nasdaq GlobeNewswire

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

15 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

11 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

06 4 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

04 4 2023 08:00:00 提供 Nasdaq GlobeNewswire

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

30 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

23 3 2023 08:00:00 提供 Nasdaq GlobeNewswire